Variant report
Variant | esv3323015 |
---|---|
Chromosome Location | chr4:118400104-118401152 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150986455 | chr4:118400112-118400113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115514539 | chr4:118400116-118400117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569878116 | chr4:118400176-118400177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140858579 | chr4:118400211-118400212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77442421 | chr4:118400213-118400214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146268416 | chr4:118400316-118400317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs28701752 | chr4:118400337-118400338 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs554557937 | chr4:118400410-118400411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111205529 | chr4:118400452-118400453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568197260 | chr4:118400587-118400588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141164474 | chr4:118400600-118400601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528676941 | chr4:118400707-118400708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573627209 | chr4:118400712-118400713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557265900 | chr4:118400755-118400756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146952040 | chr4:118400767-118400768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10032856 | chr4:118400825-118400826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186470918 | chr4:118400837-118400838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377442234 | chr4:118400838-118400839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575933073 | chr4:118400869-118400870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370343375 | chr4:118400877-118400878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541012677 | chr4:118400888-118400889 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560895621 | chr4:118400892-118400893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529811431 | chr4:118400901-118400902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111625741 | chr4:118400903-118400904 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139979298 | chr4:118400922-118400923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190663835 | chr4:118400938-118400939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563246857 | chr4:118400940-118400941 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532285364 | chr4:118400943-118400944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200562397 | chr4:118400992-118400993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149487460 | chr4:118401014-118401015 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528402111 | chr4:118401027-118401028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113280339 | chr4:118401053-118401054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562381702 | chr4:118401094-118401095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544774853 | chr4:118401131-118401132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Schizophrenia | 23813976 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:118388000-118400800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:118396600-118402800 | Weak transcription | HMEC | breast |
3 | chr4:118399400-118401200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr4:118399800-118402200 | Weak transcription | NHEK | skin |
5 | chr4:118400000-118401200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:118400800-118401200 | Enhancers | Left Ventricle | heart |
7 | chr4:118400800-118401400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |